文献速递消化道肿瘤与早癌胰腺与胆道疾病

单细胞综合分析揭示胆囊癌发病机制中的微环境动态与免疫调节因子嗅素4

Comprehensive single-cell analysis deciphered microenvironmental dynamics and immune regulator olfactomedin 4 in pathogenesis of gallbladder cancer.
PubMed 文献 · Gut · 2024-08-08

本研究对230737个细胞进行单细胞转录组分析,样本来自15例胆囊癌、4例胆囊炎、3例胆囊息肉、5例胆囊腺瘤及16例癌旁正常组织,并通过组织学与空间蛋白组学验证。研究发现胆囊癌免疫微环境更呈抑制性,间质与免疫细胞互斥,SC1亚群与不良预后相关,上皮细胞中嗅素4(OLFM4)升高通过MAPK-AP1轴上调PD-L1促进免疫逃逸,提示OLFM4为潜在生物标志物和治疗靶点。

要点

  • 胆囊癌呈现更抑制的免疫微环境,不同亚型T细胞增殖模式和巨噬细胞属性各异。
  • 间质细胞与免疫细胞呈互斥性,SC1亚群(Fibro-iCAF与Endo-Tip活跃互作)与不良预后相关。
  • 上皮细胞OLFM4升高通过MAPK-AP1轴上调PD-L1促进肿瘤免疫逃逸,与T细胞功能障碍和肿瘤相关巨噬细胞浸润相关,导致更差预后。

核心结论

  • 本研究为理解胆囊疾病发病机制提供了宝贵资源,并提示OLFM4可作为胆囊癌的潜在生物标志物和治疗靶点。

研究设计与样本

  • 对来自15例胆囊癌、4例胆囊炎、3例胆囊息肉、5例胆囊腺瘤和16例癌旁正常组织的230737个细胞进行单细胞转录组分析。
  • 通过大规模组织学检测和数字空间分析多重免疫荧光(GeoMx)等验证发现。
  • 通过体外和体内研究进一步阐明分子机制。

主要发现

  • 细胞图谱揭示了胆囊疾病不同病理状态下免疫格局的改变。
  • 胆囊癌具有更抑制的免疫微环境,不同胆囊癌亚型中T细胞增殖模式和巨噬细胞属性各异。
  • 发现间质细胞与免疫细胞互斥,并揭示胆囊癌进展过程中显著的间质生态系统(SC)异质性。
  • SC1显示Fibro-iCAF与Endo-Tip细胞间活跃互作,与不良预后相关。
  • 腺癌(AC)上皮基因变异提示腺瘤与腺癌之间的演化相似性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Elucidating complex ecosystems and molecular features of gallbladder cancer (GBC) and benign gallbladder diseases is pivotal to proactive cancer prevention and optimal therapeutic intervention. DESIGN: We performed single-cell transcriptome analysis on 230 737 cells from 15 GBCs, 4 cholecystitis samples, 3 gallbladder polyps, 5 gallbladder adenomas and 16 adjacent normal tissues. Findings were validated through large-scale histological assays, digital spatial profiler multiplexed immunofluorescence (GeoMx), etc. Further molecular mechanism was demonstrated with in vitro and in vivo studies. RESULTS: The cell atlas unveiled an altered immune landscape across different pathological states of gallbladder diseases. GBC featured a more suppressive immune microenvironment with distinct T-cell proliferation patterns and macrophage attributions in different GBC subtypes. Notably, mutual exclusivity between stromal and immune cells was identified and remarkable stromal ecosystem (SC) heterogeneity during GBC progression was unveiled. Specifically, SC1 demonstrated active interaction between Fibro-iCAF and Endo-Tip cells, correlating with poor prognosis. Moreover, epithelium genetic variations within adenocarcinoma (AC) indicated an evolutionary similarity between adenoma and AC. Importantly, our study identified elevated olfactomedin 4 (OLFM4) in epithelial cells as a central player in GBC progression. OLFM4 was related to T-cell malfunction and tumour-associated macrophage infiltration, leading to a worse prognosis in GBC. Further investigations revealed that OLFM4 upregulated programmed death-ligand 1 (PD-L1) expression through the MAPK-AP1 axis, facilitating tumour cell immune evasion. CONCLUSION: These findings offer a valuable resource for understanding the pathogenesis of gallbladder diseases and indicate OLFM4 as a potential biomarker and therapeutic target for GBC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. He H, Chen S, Yu Y, et al. Comprehensive single-cell analysis deciphered microenvironmental dynamics and immune regulator olfactomedin 4 in pathogenesis of gallbladder cancer. Gut. 2024. PMID: 38719336. doi:10.1136/gutjnl-2023-331773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。